Differential Diagnosis of Psychotic Disorder with High Creatine Kinase and Subfebrile Fever : A Case Report

Catatonia is a syndrome, comprised of symptoms such as excessive motor activity, extreme negativism, motor immobility, and stereotyped movements. The malignant form of catatonia (MC) is considered to be a fatal and rapidly progressive subtype. It is a rare condition that pres¬ents subtle signs and symptoms and different etiologies, and is therefore underdiagnosed. Neuroleptic malignant syndrome (NMS) is an uncommon but potentially fatal idiosyncratic reaction to neuroleptics and characterized by a distinctive clinical syndrome of mental status change, rigidity, fever, and dysautonomia. MC resembles NMS in many ways but was described long before the introduction of neuroleptics. Cotard and capgras delusions may be associated with MC and NMS. The present case report demonstrates the difficulty of correctly diagnosing MC, NMS and emphasizes the importance of symptom chronology while going to take a diagnosis.

[1]  T. Becker,et al.  Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma , 2014, Psychopharmacology.

[2]  J. Serra-Mestres,et al.  Catatonia in the emergency department , 2012, Emergency Medicine Journal.

[3]  H. Karasoy,et al.  Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl , 2007, Clinical toxicology.

[4]  J. Yen,et al.  Zotepine‐Induced Catatonia as a Precursor in the Progression to Neuroleptic Malignant Syndrome , 2005, Pharmacotherapy.

[5]  H. Möller,et al.  Severe and uncommon involuntary movement disorders due to psychotropic drugs. , 2004, Pharmacopsychiatry.

[6]  F. Ünal,et al.  Reliability and Validity of Schedule for Affective Disorders and Schizophrenia for School Age Children-Present and Lifetime Version-Turkish Version (K-SADS-PL-T) - , 2004 .

[7]  M. Fink,et al.  Catatonia in psychiatric classification: a home of its own. , 2003, The American journal of psychiatry.

[8]  A. Rothner,et al.  Topical Review : Neuroleptic Malignant Syndrome in Children and Adolescents , 2001 .

[9]  A. Rothner,et al.  Neuroleptic malignant syndrome in children and adolescents. , 2001, Journal of child neurology.

[10]  Y. A. Aderibigbe,et al.  Proposed research diagnostic criteria for neuroleptic malignant syndrome. , 1999, The international journal of neuropsychopharmacology.

[11]  J. Levenson,et al.  Neuroleptic malignant syndrome: a review. , 1998, Psychiatric services.

[12]  R. Clark,et al.  Neuroleptic malignant syndrome presenting without fever: case report and review of the literature. , 1994, The Journal of emergency medicine.

[13]  V. Velamoor,et al.  Incipient Neuroleptic Malignant Syndrome? , 1990, British Journal of Psychiatry.

[14]  J. Levenson Clinical Differentiation Between Lethal Catatonia and Neuroleptic Malignant Syndrome , 1989 .

[15]  C. Clarke,et al.  Neuroleptic malignant syndrome. , 1989, Lancet.

[16]  S. Caroff,et al.  Lethal catatonia. , 1986, The American journal of psychiatry.